Protalix BioTherapeutics, Inc. - PLX

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 14
Latest filed: Sep 09, 2026
Form Count
4 9
8-K 4
SCHEDULE 13G/A 1

Latest files

Filed Form Report period Accession SEC
Sep 09, 2026 4 Sep 03, 2026 0001178913-26-004471 View
Sep 04, 2026 4 Sep 03, 2026 0001831558-26-000003 View
Sep 04, 2026 4 Sep 03, 2026 0001935668-26-000002 View
Sep 04, 2026 4 Sep 03, 2026 0001385113-26-000002 View
Sep 04, 2026 4 Sep 03, 2026 0001781450-26-000002 View
Sep 04, 2026 4 Sep 03, 2026 0001454771-26-000002 View
Sep 04, 2026 4 Sep 03, 2026 0001614890-26-000002 View
Sep 04, 2026 4 Sep 03, 2026 0002075661-26-000002 View
Sep 04, 2026 4 Sep 03, 2026 0001742727-26-000002 View
Aug 12, 2026 8-K Aug 12, 2026 0001104659-26-094433 View
Jun 25, 2026 8-K Jun 25, 2026 0001104659-26-077790 View
May 21, 2026 8-K May 21, 2026 0001104659-26-064850 View
May 13, 2026 8-K May 13, 2026 0001104659-26-059749 View
Mar 30, 2026 SCHEDULE 13G/A — 0001426156-26-000006 View